Supplementation with DHA in children with non-alcoholic fatty liver disease showed a decrease of fatty liver [28] and a significant reduction in pericardiac and visceral fat, and also in triglycerides and fasting insulin after 6 months of treatment [29]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.